Trial Halted for Bleeding Reduction With Abelacimab in AF ...Middle East

The phase 2 AZALEA-TIMI 71 trial in AF shows "an overwhelming reduction" in major and clinically relevant nonmajor bleeding with investigational Factor XI inhibitor abelacimab vs rivaroxaban. Medscape Medical News

Hence then, the article about trial halted for bleeding reduction with abelacimab in af was published today ( Tuesday 19/09/2023 - 07:40 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Trial Halted for Bleeding Reduction With Abelacimab in AF )

Also on site :

• Zendaya to Miss 2026 Met Gala Amid Busy Year of Releases
• 1972 Classic Rock Hit Was Released 54 Years Ago Today
• Meta buys robotic startup to bolster its humanoid AI ambitions